This document by Neurocrine Biosciences, INC discusses how serious mental illness (SMI) and tardive dyskinesia (TD) affect people across different racial and ethnic groups in the United States.
While SMI and TD affect all populations, this document dives into statistics behind how racial and ethnic minority groups often face more barriers to diagnosis, treatment, and monitoring.
To learn more, download the supporting document here.
Contributor: Neurocrine Biosciences
Recent Posts
- Neurosurgery for psychiatric disorders: reviewing the past and charting the future in: Neurosurgical Focus Volume 54 Issue 2 (2023) Journals
- Synchronized cervical VNS with accelerated theta burst TMS for treatment resistant depression - Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation
- Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials
